Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

NCT03439657 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

913

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: HZ/su vaccine GSK1437173A
BIOLOGICAL: Prevenar13

Sponsor

GlaxoSmithKline